| Literature DB >> 35717627 |
Eric Emerson1,2, Zoe Aitken3,4, Vaso Totsika5,6,7, Tania King4, Roger J Stancliffe3,8, Chris Hatton9, Gwynnyth Llewellyn3,8, Richard P Hastings6,7, Anne Kavanagh3,4.
Abstract
Concern has been expressed about the extent to which people with disabilities may be particularly vulnerable to negative impacts of the 2020 COVID-19 pandemic. However, to date little published research has attempted to characterise or quantify the risks faced by people with/without disabilities in relation to COVID-19. We sought to compare the impact of the early stages of the COVID-19 pandemic and associated government responses among working age adults with and without disabilities in the UK on; COVID-19 outcomes, health and wellbeing, employment and financial security, health behaviours, and conflict and trust. We undertook secondary analysis of data collected in four UK longitudinal surveys; the Millennium Cohort Study, Next Steps, the British Cohort Study and the National Child Development Study. Combining analyses across surveys with random effects meta-analysis, there was evidence that people with disabilities were significantly more likely to report having had COVID-19 and had significantly increased levels of stress, less exercise, poorer sleep patterns, more conflict with their partner and others in their local area, and to have less trust in the government. While most outcomes did not differ significantly between participants with and without disability, the findings suggest that in the early days of COVID-19 a detrimental impact emerges for those with disabilities which is more pronounced among older people with disabilities. Future research is needed to determine the longer-term impact of the pandemic.Entities:
Keywords: COVID-19; adults; conflict; disability; stress; trust; wellbeing
Year: 2022 PMID: 35717627 PMCID: PMC9349993 DOI: 10.1111/hsc.13882
Source DB: PubMed Journal: Health Soc Care Community ISSN: 0966-0410
Outcome variables from may 2020 COVID‐19 questionnaire
| Outcomes | Form | Details | Missing data |
|---|---|---|---|
| Health and wellbeing | |||
| Self‐rated health | Pre/post | ‘In general, would you say your health is/was … excellent, very good, good, fair, poor’. Recoded as a binary variable; self‐rated health currently poorer than in 3 months preceding pandemic (vs. not) | 0.4% |
| Self‐rated stress | Judgement | ‘Since the Coronavirus outbreak please indicate how the following have changed …. The amount of stress I've been feeling … more than before, same—no change, less than before’. Recoded as a binary variable; stress ‘more than before’ (vs. not) | 10.6% |
| Financial status and economic activity | |||
| Financial status | Judgement | ‘Overall, how do you feel your | 5.8% |
| Economic activity | Pre/post | ‘Which of these best describes what you were doing just | 0.9% |
| Health behaviours | |||
| Cigarettes smoked | Pre/post | ‘In the month | 7.5% |
| Vaping | Judgement |
‘Since the start of the Coronavirus outbreak, has the amount you have been using an electronic cigarette or vaping device changed? Yes—I have used an electronic cigarette or vaping device more often, Yes—I have used an electronic cigarette or vaping device less often, No Recoded as a binary variable; currently vaping more than previously (vs. not) | 8.0% |
| Alcohol use | Pre/post | ‘In the month | 7.4% |
| Exercise | Pre/post | ‘In the month | 9.7% |
| Fruit/veg consumption | Pre/post | ‘In the month | 12.0% |
| Sleep | Pre/post | ‘In the month | 8.6% |
| Conflict and trust | |||
| Relationship conflict | Judgement | ‘Since the Coronavirus outbreak began, has the amount you have argued with your partner changed? My partner and I have argued more often, No change—same as before, My partner and I have argued less often.’ Recoded as a binary variable; conflict ‘more than before’ (vs. not). Note: missing data calculated for respondents in a cohabiting or non‐cohabiting relationship. | 0.5% |
| Conflict with other people | Judgement | ‘Since the Coronavirus outbreak please indicate how the following have changed …. The amount of conflict I have had with people around me … more than before, same—no change, less than before’. Recoded as a binary variable; conflict ‘more than before’ (vs. not) | 10.9% |
| Trust in government | Judgement | ‘Since the Coronavirus outbreak please indicate how the following have changed …. The amount of trust I have in the Government … more than before, same—no change, less than before’. Recoded as a binary variable; trust ‘less than before’ (vs. not) | 11.1% |
| Trust in people in local area | Judgement | ‘Since the Coronavirus outbreak please indicate how the following have changed …. The amount of trust I have in people in my local area … more than before, same—no change, less than before’. Recoded as a binary variable; trust ‘less than before’ (vs. not) | 10.8% |
Note: Pre/post—respondents were asked to retrospectively estimate lifestyle in the 3 months prior to pandemic and, separately, in May 2020. Judgement—respondents were asked to estimate change in lifestyle comparing the 3 months prior to pandemic with May 2020.
Characteristics of respondents to the may 2020 COVID‐19 questionnaire for the four cohort studies
| Millennium Cohort Study | Next Steps | BCS70 | National Child Development Study | |
|---|---|---|---|---|
| Response rate | 26.6% | 20.3% | 40.4% | 57.9% |
| Sample size (unweighted, total) | 2629 | 1858 | 4223 | 5178 |
| Sample size (unweighted, with valid disability information) | 2575 | 1706 | 3656 | 4837 |
| Age (in years) in May 2020 | 19 | 30 | 50 | 62 |
| Age (in years) when disability status was determined | 17 | 25 | 46 | 55 |
| Weighted % female | 50.6% | 56.6% | 48.7% | 51.0% |
| Weighted % with disability | 9.7% | 11.9% | 21.1% | 20.2% |
| Living situation | ||||
| With disability: living with partner | 6.5% | 44.8% | 57.3% | 78.6% |
| No disability: living with partner | 6.9% | 67.8% | 72.8% | 83.3% |
| With disability: living with parent(s) | 85.3% | 36.4% | 5.8% | 2.4% |
| No disability: living with parent(s) | 87.7% | 17.8% | 3.8% | 2.7% |
Outcomes disaggregated by cohort
| Outcome | Millennium Cohort Study (19) | Next Steps (30) | BCS70 (50) | National Child Development Study (62) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PWD | Others | APRR1 | APRR2 | PWD | Others | APRR1 | APRR2 | PWD | Others | APRR1 | APRR2 | PWD | Others | APRR1 | APRR2 | |
| COVID‐19 | ||||||||||||||||
| Has had COVID | 7.7% (4.2–13.7) | 5.0% (3.9–6.4) | 1.48 (0.77–2.82) | 1.46 (0.77–2.80) | 8.1% (4.5–14.3) | 10.2% (8.0–13.0) | 0.82 (0.44–1.52) | 0.81 (0.43–1.53) | 12.7% (10.2–15.7) | 9.1% (8.1–10.1) | 1.39 (0.81–2.39) | 1.00 (0.69–1.46) | 8.7% (6.9–10.9) | 4.9% (4.3–5.6) | 1.76 (1.11–2.80) | 1.43 (0.99–2.07) |
| Potential key COVID symptom in last 2 weeks | 19.5% (13.9–26.7) | 22.3% (19.3–25.6) | 0.87 (0.61–1.24) | 0.88 (0.62–1.24) | 16.1% (9.9–25.3) | 14.9% (11.9–18.6) | 1.07 (0.65–1.76) | 1.05 (0.64–1.73) | 40.7% (36.7–44.8) | 18.1% (16.7–19.4) | 2.27 (1.80–2.88) | 2.03 (1.72–2.41) | 28.7% (25.6–31.9) | 18.8% (17.7–20.1) | 1.52 (1.22–1.89) | 1.48 (1.20–1.82) |
| Fever | 3.6% (1.6–7.7) | 2.5% (1.8–3.6) | 1.36 (0.58–3.16) | 1.28 (0.57–2.87) | 3.8% (1.7–8.2) | 4.1% (2.4–6.6) | 0.89 (0.35–2.23) | 0.92 (0.35–2.38) | 12.7% (10.2–15.7) | 3.2% (2.7–3.9)) | 3.91 (1.85–8.28) | 2.61 (1.39–4.92) | 3.4% (2.3–4.9) | 2.1% (1.7–2.6) | 1.52 (0.89–2.59) | 1.82 (1.06–3.12) |
| Cough | 17.9% (12.5–25.0) | 20.0% (17.0–23.3) | 0.90 (0.61–1.31) | 0.90 (0.62–1.31) | 14.5% (8.5–23.6) | 11.3% (8.9–14.4) | 1.28 (0.74–2.22) | 1.25 (0.73–2.15) | 36.0% (32.2–40.1) | 15.7% (14.4–17.0) | 2.30 (1.77–3.00) | 2.03 (1.69–2.42) | 25.9% (23.0–29.1) | 16.4% (15.3–17.7) | 1.59 (1.25–2.01) | 1.48 (1.18–1.86) |
| Loss of taste or smell | 1.9% (0.9–4.0) | 2.6% (1.7–4.0) | 0.72 (0.31–1.64) | 0.68 (0.30–1.58) | 2.3% (0.7–7.2) | 3.2% (1.8–5.6) | 0.69 (0.18–2.51) | 0.78 (0.21–2.84) | 7.7% (5.7–10.2) | 4.1% (3.4–4.8) | 1.87 (0.86–4.08) | 1.86 (1.12–3.10) | 4.9% (3.6–6.6) | 2.9% (2.4–3.4) | 1.63 (0.90–2.96) | 1.99 (1.14–3.45) |
| Tested for COVID | 4.0% (1.7–9.2) | 2.1% (1.3–3.6) | 1.92 (0.68–4.43) | 1.95 (0.70–5.41) | 6.8% (3.0–14.9) | 3.7% (2.2–6.2) | 1.81 (0.70–4.65) | 1.99 (0.76–5.16) | 2.9% (1.8–4.7) | 3.7% (3.1–4.4) | 0.78 (0.36–1.66) | 0.73 (0.44–1.24) | 4.5% (3.2–6.1) | 2.2% (1.8–2.7) | 1.99 (0.76–5.18) | 1.56 (0.81–2.99) |
| Tested for COVID if symptomatic in last 2 weeks | 7.6% (1.9–26.3) | 4.1% (1.9–8.9) | 1.63 (0.25–10.72) | 1.54 (0.30–7.83) | 14.8% (4.7–37.8) | 13.3% (6.6–24.9) | 1.22 (0.35–4.27) | 2.02 (0.61–6.65) | 4.5% (2.9–7.0) | 9.5% (8.2–11.0) | 0.32 (0.15–0.69) | 0.55 (0.24–1.22) | 12.3% (8.5–17.5) | 2.7% (1.7–4.1) | 4.63 (1.44–14.89) | 1.94 (0.66–5.76) |
| Admitted to hospital for COVID | 0.0% (0.0–5.7) | 0.5% (0.2–1.5) | n/a | n/a | 2.1% (0.5–8.4) | 2.1% (0.6–7.0) | 0.82 (0.12–5.60) | 0.95 (0.12–7.38) | 0.4% (0.1–2.6) | 0.9% (0.5–1.8) | 0.37 (0.06–2.21) | 0.42 (0.12–1.52) | 1.2% 0.4–3.6) | 0.7% (0.3–1.5) | 1.75 (0.52–5.84) | 1.86 (0.55–6.22) |
| Self‐rated health and stress | ||||||||||||||||
| Self‐rated health poorer | 2.6% (1.2–5.6) | 2.6% (1.5–4.4) | 1.00 (0.41–2.43) | 1.03 (0.43–2.47) | 4.8% (2.0–11.1) | 1.0% (0.6–1.9) | 4.70 (1.66–13.35) | 4.59 (1.75–12.07) | 1.8% (1.0–3.4) | 1.8% (1.3–2.3) | 0.74 (0.26–2.16) | 0.80 (0.37–1.73) | 3.2% (2.2–4.7) | 1.6% (1.3–2.1) | 2.08 (1.09–3.97) | 2.13 (1.07–4.22) |
| Stress increased | 61.5% (53.7–68.7) | 35.2% (32.1–38.4) | 1.59 (1.34–1.87) | 1.57 (1.34–1.85) | 61.5% (48.7–72.9) | 42.8% (38.6–47.1) | 1.42 (1.12–1.80) | 1.43 (1.13–1.81) | 49.3% (45.1–53.6) | 35.0% (33.3–36.8) | 1.37 (1.16–1.62) | 1.29 (1.15–1.45) | 40.0% (36.4–43.5) | 31.1% (29.6–32.6) | 1.19 (1.01–1.41) | 1.30 (1.13–1.50) |
| Health behaviours | ||||||||||||||||
| Smoking more | 5.9% (3.6–9.6) | 5.8% (4.7–7.2) | 0.71 (0.42–1.18) | 0.79 (0.48–1.30) | 33.3% (12.5–63.7) | 20.5% (12.4–32.0) | 1.49 (0.58–3.81) | 1.41 (0.57–3.47) | 18.2% (11.0–28.5) | 13.3% (10.1–17.3) | 1.42 (0.63–3.19) | 1.29 (0.76–2.19) | 5.2% (1.8–14.0) | 9.6% (6.8–13.5) | 0.53 (0.15–1.86) | 0.23 (0.07–0.81) |
| Vaping more | 72.4% (46.0–89.0) | 43.9% (30.8–58.0) | 1.65 (1.04–2.62) | 1.44 (0.91–2.04) | 44.7% (15.7–77.8) | 49.3% (32.8–66.0) | 0.91 (0.37–2.22) | 1.34 (0.53–3.41) | 20.4% (11.9–32.8) | 25.2% (19.7–31.6) | 0.82 (0.36–1.87) | 0.86 (0.48–1.54) | 40.1% (27.2–54.5) | 28.5% (22.0–36.0) | 1.49 (0.81–2.71) | 1.47 (0.81–2.67) |
| Drinking more | 32.5% (25.1–40.9) | 42.2% (39.1–45.4) | 0.67 (0.49–0.91) | 0.71 (0.53–0.94) | 32.8% (20.0–48.9) | 19.8% (16.2–24.0) | 1.65 (0.99–2.75) | 1.59 (1.00–2.53) | 16.8% (13.3–21.0) | 9.7% (8.60–10.9) | 1.65 (1.01–2.71) | 1.53 (1.09–2.14) | 7.6% (5.7–10.1) | 9.5% (8.5–10.5) | 0.85 (0.61–1.18) | 0.87 (0.63–1.22) |
| Exercising less | 31.7% (21.7–43.7) | 29.2% (26.3–32.3) | 1.13 (0.79–1.62) | 1.13 (0.86–1.50) | 30.2% (19.1–44.3) | 29.6% (25.9–33.7) | 1.03 (0.67–1.59) | 1.02 (0.66–1.57) | 24.8% (21.2–28.8) | 20.2% (18.8–21.7) | 1.19 (0.88–1.62) | 1.19 (0.96–1.47) | 20.2% (17.5–23.3) | 17.6% (16.4–18.8) | 1.15 (0.83–1.55) | 0.93 (0.74–1.17) |
| Less fruit and veg | 8.1% (4.8–13.3) | 15.1% (13.1–17.3) | 0.57 (0.31–0.90) | 0.57 (0.33–0.97) | 22.7% (14.7–30.2) | 14.7% (12.3–17.6) | 1.54 (1.01–2.35) | 1.57 (1.03–2.38) | 19.1% (15.9–22.8) | 14.5% (13.2–15.8) | 1.30 (0.92–1.84) | 1.19 (0.94–1.51) | 17.0% (14.4–20.0) | 8.1% (7.4–9.1) | 1.94 (1.37–2.75) | 1.98 (1.41–2.77) |
| Sleeping less | 22.5% (16.4–30.1) | 21.5% (18.5–24.9) | 1.09 (0.74–1.47) | 1.11 (0.79–1.55) | 40.5% (28.2–54.2) | 19.6% (16.8–22.8) | 2.05 (1.41–3.00) | 2.09 (1.44–3.03) | 20.9% (17.6–24.7) | 18.6% (17.2–20.1) | 1.14 (0.87–1.49) | 1.20 (1.00–1.45) | 25.3% (22.2–28.5) | 14.4% (13.3–15.5) | 1.61 (1.21–2.14) | 1.47 (1.13–1.93) |
| Conflict and trust | ||||||||||||||||
| More conflict with partner | 36.8% (25.4–50.1) | 31.9% (27.5–36.6) | 1.12 (0.78–1.59) | 1.17 (0.83–1.65) | 23.2% (13.3–37.4) | 18.5% (14.9–22.8) | 1.22 (0.70–2.11) | 1.19 (0.69–2.06) | 14.7% (11.6–18.3) | 9.0% (8.0–10.2) | 1.56 (1.02–2.38) | 1.57 (1.19–2.08) | 16.5% (13.8–19.7) | 7.3% (6.5–8.2) | 2.18 (1.39–3.43) | 1.88 (1.28–2.76) |
| More conflict with others | 25.5% (18.6–33.8) | 20.0% (17.7–22.6) | 1.22 (0.88–1.70) | 1.23 (0.89–1.70) | 21.3% (12.6–33.6) | 8.9% (6.8–11.5) | 2.37 (1.35–4.17) | 2.39 (1.37–4.18) | 9.0% (6.8–11.8) | 7.6% (6.7–8.6) | 1.15 (0.74–1.79) | 1.20 (0.86–1.68) | 9.4% (7.5–11.7) | 3.5% (3.0–4.1) | 2.57 (1.52–4.34) | 2.16 (1.35–3.44) |
| Less trust in government | 33.7% (25.6–43.0) | 27.3% (23.6–31.3) | 1.23 (0.93–1.64) | 1.22 (0.91–1.64) | 47.1% (34.4–60.1) | 28.7% (25.2–32.5) | 1.65 (1.20–2.27) | 1.65 (1.21–2.25) | 30.8% (27.0–34.8) | 21.2% (19.8–22.7) | 1.44 (1.11–1.87) | 1.27 (1.05–1.53) | 29.7% (26.5–33.1) | 22.6% (21.3–24.0) | 1.33 (1.04–1.68) | 1.27 (1.02–1.57) |
| Less trust in others | 13.2% (8.5–19.9) | 16.5% (13.9–19.4) | 0.78 (0.50–1.23) | 0.77 (0.48–1.22) | 20.1% (11.7–32.4) | 12.7% (9.9–16.2) | 1.58 (0.90–2.79) | 1.60 (0.91–2.80) | 14.8% (12.0–18.1) | 7.0% (6.2–8.0) | 2.11 (1.36–3.28) | 1.62 (1.18–2.24) | 7.1% (5.4–9.1) | 5.4% (4.7–6.2) | 1.24 (0.59–2.58) | 1.34 (0.65–2.81) |
| Employment and financial situation | ||||||||||||||||
| Lost employment | 15.5% (7.9–28.2) | 17.2% (13.0–22.4) | 1.04 (0.54–1.91) | 0.97 (0.52–1.81) | 4.2% (1.8–9.2) | 8.1% (5.9–11.2) | 0.49 (0.21–1.14) | 0.49 (0.22–1.13) | 13.8% (10.7–17.5) | 12.4% (11.2–13.7) | 1.13 (0.73–1.75) | 0.97 (0.73–1.29) | 16.1% (12.6–20.4) | 18.4% (16.8–20.0) | 0.92 (0.65–1.29) | 0.91 (0.65–1.28) |
| Financially worse off | 29.8% (22.4–38.4) | 27.5% (24.5–30.7) | 1.08 (0.82–1.42) | 1.08 (0.82–1.43) | 19.5% (9.4–36.1) | 11.6% (8.7–15.2) | 1.68 (0.80–3.50) | 1.11 (0.78–1.60) | 37.7% (33.7–41.8) | 35.0% (33.3–36.7) | 1.07 (0.66–1.44) | 1.11 (0.96–1.28) | 28.8% (25.7–32.1) | 32.0% (30.6–33.5) | 0.92 (0.74–1.16) | 0.89 (0.75–1.10) |
Abbreviation: PWD, people with disabilities.
Cohort age at time of COVID‐19 survey.
Analyses restricted to respondents who smoked/vaped pre‐pandemic.
p < 0.05
p < 0.01
p < 0.001.
Adjusted prevalence rate ratios (APPR) combined across cohorts comparing outcomes between people with and without disability
| APRR1 |
| APRR2 |
| |
|---|---|---|---|---|
| COVID‐19 | ||||
| Has had COVID | 1.38 (1.06–1.79) | 7.4 | 1.16 (0.90–1.51) | 18.5 |
| Key COVID symptom in last 2 weeks | 1.39 (0.91–2.10) | 95.1 | 1.33 (0.91–1.93) | 87.3 |
| Fever | 1.75 (0.92–3.29) | 71.5 | 2.01 (1.45–2.80) | 0.0 |
| Cough | 1.48 (0.98–2.23) | 86.5 | 1.40 (0.99–1.99) | 82.7 |
| Loss of taste or smell | 1.28 (0.79–2.10) | 41.4 | 1.36 (0.80–2.32) | 54.5 |
| Tested for COVID | 1.36 (0.78–2.39) | 43.8 | 1.30 (0.75–2.27) | 54.2 |
| Tested for COVID if key COVID symptom in last 2 weeks | 1.11 (0.33–3.74) | 76.2 | 1.19 (0.52–2.72) | 60.7 |
| Admitted to hospital for COVID | 0.82 (0.29–2.34) | 38.8 | 0.89 (0.30–2.61) | 39.0 |
| Self‐rated health and stress | ||||
| Self‐rated health poorer | 1.58 (0.74–3.39) | 71.0 | 1.65 (0.79–3.42) | 69.3 |
| Stress increased | 1.38 (1.23–1.55) | 49.1 | 1.38 (1.24–1.51) | 36.1 |
| Health behaviours | ||||
| Smoking more | 0.99 (0.62–1.58) | 39.1 | 0.88 (0.50–1.55) | 60.4 |
| Vaping more | 1.23 (0.85–1.79) | 34.4 | 1.26 (0.94–1.70) | 0.0 |
| Drinking more | 1.09 (0.70–1.73) | 84.3 | 1.08 (0.73–1.62) | 80.9 |
| Exercising less | 1.16 (1.00–1.34) | 0.0 | 1.07 (0.93–1.23) | 10.1 |
| Less fruit and veg | 1.26 (0.78–2.03) | 85.2 | 1.23 (0.74–2.03) | 86.8 |
| Sleeping less | 1.40 (1.06–1.86) | 73.4 | 1.39 (1.09–1.79) | 67.7 |
| Conflict and trust | ||||
| More conflict with partner | 1.46 (1.05–1.73) | 32.9 | 1.40 (1.11–1.93) | 49.1 |
| More conflict with others | 1.63 (1.08–2.46) | 74.7 | 1.58 (1.12–2.23) | 65.1 |
| Less trust in government | 1.40 (1.25–1.58) | 0.0 | 1.31 (1.16–1.48) | 0.0 |
| Less trust in others | 1.36 (0.86–2.18) | 72.5 | 1.28 (0.87–1.87) | 58.6 |
| Employment and financial situation | ||||
| Lost employment | 0.99 (0.80–1.21) | 0.0 | 0.90 (0.77–1.06) | 0.0 |
| Financially worse off | 1.04 (0.93–1.16) | 0.0 | 1.04 (0.92–1.17) | 18.5 |
Note: APRR1 adjusted for gender; APRR2 adjusted for gender and childhood socio‐economic position. I 2 the percentage of total variation in study estimates that is due to heterogeneity.
Analyses restricted to respondents who smoked/vaped pre‐pandemic.
p < 0.05
p < 0.01
p < 0.001.